Fewer people under age 50 are dying from cancer in the U.S., but colorectal cancer mortality rates continue to surge ...

A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...

Recent findings suggest no significant overall survival difference for patients with locally advanced esophageal squamous cell carcinoma who had neoadjuvant vs adjuvant therapy.

Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients ...

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone ...